ATS 2024 Final Program

Click on the session title to view the speakers

152

MONDAY • MAY 20

P1215 Respiratory Viral Infections and Diagnosis of Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplant P1216 Evolving Trends in Underlying Etiologies for Lung Transplantation, Overall Survival, but Not in Freedom From CLAD-BOS P1217 Radiology and Pathology Features in Short Telomere Patients With Interstitial Lung Disease Undergoing Transplant P1218 Data Driven Lung Function Trajectories Post-Transplantion Illuminate Modifiable Risk Factors P1219 Navigating Airway Challenges After Lung Transplantation P1220 Risk Factors for Development of Venous Thromboembolism After Lung Transplant P1221 Oropharyngeal Dysphagia in Patients With Lung Transplant: A Modifiable Risk Factor P1222 Preoperative Anemia as a Risk Factor for Post Operative Outcomes in Patients Undergoing Lung Transplant P1223 Safety and Tolerability of SGLT-2 Inhibitors Following Lung Transplantation P1224 Comparing Lung Allocation Scores and Wait List Duration of Transplanted Patients With Interstitial Lung Disease Referred From Specialty and Community Settings P1225 Early Versus Late Tracheostomy in Post-operative Lung Transplant Recipients P1226 A Pilot Study to Determine Outcomes in Lung Transplant Recipients Using Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors P1227 The Prevalence and Evaluation of Anemia in Lung Transplant Recipients: A Single Center Experience P1228 Mycophenolate-induced Colitis in Lung Transplant Recipients P1229 Predictive Biomarkers of VTE in Patients After Lung Transplantation P1230 Belatacept Use for Renal-sparing Immunosuppression in Lung Transplant

CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION

B47 LUNG TRANSPLANT 9:15 a.m. - 4:15 p.m.

San Diego Convention Center Area K (Hall H, Ground Level)

Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees P1205 Do Eosinophils Predict Mortality? A Case Series of Lung Transplant Recipients With Acute Fibrinous Organizing Pneumonia P1206 Transplant Outcomes for Patients With Connective Tissue Disease-related Interstitial Lung Disease P1207 The Hispanic Paradox in Lung Transplant Outcomes: Disentangling the Roles of Primary Diagnosis, Monitoring Period, Age, and Era P1208 Impact of Transplant Laterality on Chronic Lung Allograft Dysfunction P1209 Cumulative Incidence of Chronic Lung Allograft Dysfunction in Lung Transplant Recipients With a Repeated 10% FEV1 Decline P1210 Outcome of Bridging to Lung Transplantation With Mechanical Ventilation or Extracorporeal Membrane Oxygenation P1211 Predictors of Survival and Clinical Outcomes Among Lung Transplant Recipients Who Require Venovenous Extracorporeal Membrane Oxygenation in the Post-transplant Period P1212 The Impact of Changes in Weight on Pulmonary Function Post-lung Transplantation P1213 Accuracy of Chronic Lung Allograft Dysfunction (CLAD) Identification and Phenotyping by Computed Tomography Using a Novel Machine Learning Algorithm P1214 Clinical Characteristics and Outcomes of Lung Transplant Recipients Receiving Extracorporeal Photopheresis (ECP) for Chronic Allograft Dysfunction (CLAD)

ATS 2024 Conference Program • San Diego, CA